acorda also has a robust pipeline. working on a nasal spray version of diazepam to help with epilepsy. a bunch of intriguing projects still in early phase one development, ultimately could pay off years down the road. on monday, it preannounced higher than expected fourth quarter sales, stock spiked, fairly bullish forecast for 2013. giving a 15% gain since we last spoke to the ceo back in june. does it have more room to run? let's check in with dr. ron cohen, the founder and ceo of acorda therapeutics. welcome back to "mad money." >> thanks very much, jim. >> i was going back to our interview in july of last year, and so much has changed. at the time you were only talking about pre-clinical or rat studies of what your drug could be for stroke. since then, i was looking at your presentation this morning -- this week. 66 people with stroke, at least six months trying this. give me the progression. there have got to be people initially happy with the post stroke deficit study. >> well, it's still a blinded study, jim. th

ron cohen the founder and ceo of acorda therapeutics. welcome back to "mad money." >> thanks very much, jim. >> i was going back to our interview in july of last year, and so much has changed. at the time you were only talking about pre-clinical or rat studies of what your drug could be for stroke. since then, i was looking at your presentation this morning -- this week. 66 people with stroke, at least six months trying this. give me the progression. there have got to be people initially happy with the study. >> well, it's still a blinded study, jim. that means we have no idea who's done well on placebo versus drug, but we're going to find out pretty soon. we're getting the results of that trial in the second quarter of this year. we're very excited to see those results. >> i think people want to understand, it's not just everybody who has had a stroke. it's particular kind of people who face a stroke problem, right? >> yeah, well, about half the people who have had a stroke wind up with permanent disabilities. as a result, reduced mobil

first up, the ceo of acorda and the ceo of charles leariver. that's coming up, top of the hour.e back. at 1:45, the aflac duck was brought in with multiple lacerations to the wing and a fractured beak. surgery was successful, but he will be in a cast until it is fully healed, possibly several months. so, if the duck isn't able to work, how will he pay for his living expenses? aflac. like his rent and car payments? aflac. what about gas and groceries? aflac. cell phone? aflac, but i doubt he'll be using his phone for quite a while cause like i said, he has a fractured beak. [ male announcer ] send the aflac duck a get-well card at getwellduck.com. office superstore ink retailer in america. now get $6 back in staples rewards for every ink cartridge you recycle when you spend $50 on hp ink. staples. that was easy. when you spend $50 on hp ink. we replaced people with a machine.r, what? customers didn't like it. so why do banks do it? hello? hello?! if your bank doesn't let you talk to a real person 24/7, you need an ally. hello? ally bank. your money needs an ally. [ male announcer